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Abstract – Aim of the study was comparing the quality of life of addicts treated in frame of methadone sub-
stitution programs and addicts undergoing the rehabilitation on the frame of therapeutic community. We 
have done a crossover study in the Center for Prevention and Out-patient Treatment in Mostar. We have 
included 60 subjects in our study. All of them were heroin addicts, referred to the Center for Prevention and 
Out-patient Treatment in Mostar, who satisfied the DSM-IV criteria for the addiction disease. The subjects 
have been divided in three groups: 1) group of just-admitted patients (N=20), 2) group of patients who had 
spent six months in methadone program (N=20) and 3) group of patient who had spent six months in the 
therapeutic community program (N=20). In this study, we have gathered data for social-demographic vari-
ables such as age, education, marital and professional status and variables related to the addiction, such 
as duration of addiction, manner of drug administration, alcohol use and presence of HCV, HBV or HIV viral 
infections. For the estimation of quality of life, we have used the “Quality of life index”, to measure the per-
ception of the important areas of life, such as health and functioning in the fields of social, economic, psy-
chological and spiritual domains. A majority of subjects from this sample had achieved the secondary school 
education and were of similar age, unmarried, mostly unemployed and only a smaller number of them were 
living alone, out of their primary families. The groups tested have not significantly differed considering those 
living conditions which reflect the quality of life. The results of addiction variables had showed that a ma-
jority of subjects administered the drug intravenously, there were no significant differences concerning the 
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Introduction
The addiction to heroin is a severe dis-
order and its treatment represents a compli-
cated, long-lasting process, which includes a 
series of  various interventions which have 
to be constantly adjusted to patients’ present 
state and his abilities to accept the therapy. 
The addiction is very resistant to treatment 
and if  the program is not at the same time, 
enough influential and persistent, but also ac-
ceptable to the addict to stick to it for months 
or even years, the expected results will not be 
achieved. Retention to the program, absti-
nence from the illicit drugs, reduction of  il-
legal activities and improving the aspects of  
socially acceptable behaviour are the best in-
dicators of  therapeutic efforts [1-5]. 
Already thirty years ago, the most of  
western-European countries and USA, Can-
ada and Australia have accepted the use of  
methadone as a recognized method for treat-
ment of  opiate addicts and a useful tool in 
the frame of  ‘harm-reduction’ approach for 
helping the not-motivated or incurable her-
oin addicts. Methadone enables those pa-
tients to stop or significantly reduce taking 
heroin. Although methadone does not create 
the feeling of  euphoria similar to the effect 
of  heroin, it replaces the biological lack of  
endorphins at the opioid receptors in brain 
and, with its help, the patient can achieve a 
psychophysical balance and control the path-
ological addict’s craving. The use of  metha-
done is the best way to attract the addicts 
from the street to the process of  treatment 
and, if  it is well organized and spread, can ul-
timately direct many addicts towards the pro-
grams that would help them in stabilizing the 
permanent abstinence [1-5].  
In the evaluation study carried out by 
the American National Institute for Drugs 
(NIDA) it has been found that the substitu-
tion therapy reduces users’ heroin intake for 
70%, and their criminal activity by 57 %. [6]. 
It has also been reported that the countries 
which use methadone attract up to 75% of  
opiate addicts to their programs, while those 
that do not use it, achieve less than 20 %, 
making the mortality of  addicts due to over-
dose very high. A large number of  addicts 
included in substitution programs function 
better socially, i.e. better fulfill their duties at 
the workplace and in families and display sig-
nificantly less dealings with criminal activities, 
particularly with selling drugs, thus reduc-
ing the risk of  initial drug abuse among the 
healthy population. Application of  metha-
done improves the physical and mental health 
duration of addiction and the most of the subjects had drunk no alcohol. We have not detected any cases 
of HIV infection, while a significant number of subjects had been infected with hepatitis B virus. This study 
revealed significant differences in quality of life between the groups tested. The groups of subjects who had 
undergone the methadone program and the group of those treated in the frame of therapeutic community 
showed significantly higher scores on quality of life scales compared to the group of just-admitted patients, 
while there were no such differences between the group of subjects who had undergone the methadone 
program and the group of those treated in the frame of therapeutic community. The data obtained indicate 
that the methadone treatment is similarly effective concerning the quality of subjects’ life as the treatment 
in the frame of therapeutic community.
Key words: opiate dependence, methadon, buprenorphin, quolity of life
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of  the addict, his life gets longer and the risk 
for early sudden death is reduced. By using 
methadone, physical and mental health of  
addicts is improved, their lifespan prolonged 
i.e. the risk of  sudden death is reduced. The 
addicts in substitution programs are less dan-
gerous concerning the spread of  HIV infec-
tion, hepatitis and encouraging others to take 
drugs. The use of  methadone in pregnancy 
is absolutely indicated: it reduces the risk of  
unwanted pregnancy termination and the risk 
of  damaging the fetus. [1]. 
“Drug free” residential treatment of  ad-
dictions in the frame of  therapeutic commu-
nities (TZ) started in early sixties as groups 
of  self  and mutual help, as an alternative 
to the existing conventional programs. The 
mean duration of  stay differs from TZ to TZ 
(18-60 months). The staff  consists mostly 
of  former addicts, while the rest of  the staff  
consists of  medical professionals from the 
field of  mental health, psychologists, defec-
tologists, and pedagogues and similar. The 
aim of  staying in TZ is a global change of  
lifestyle, including abstinence from the ille-
gal substances, elimination of  anti-social ac-
tivities, gathering skills for job-finding and 
the development of  pro-social efforts and 
values. In TZ, detoxification is the condition 
to enter the treatment and not the goal of  
it. Most of  the patients who enter TZ al-
ready have histories of  multiple drug abuse, 
significantly disturbed psychosocial func-
tioning and consequently, significantly lower 
quality of  life. The patients are mostly male, 
older than 25 years of  age, coming from 
broken families, without any significant pe-
riods of  active working and with accentu-
ated problems with the law. They frequently 
have more pronounced depression, anxiety, 
personality disorders, difficulties in thought 
process, affective disorders, i.e. whatever the 
anamnesis, the level of  psychological dam-
age is high. 
Abandoning the program happens most 
frequently during the first month of  treat-
ment and averages about 30-40%, and then 
drops during the later stages of  program. 
Finishing the program in long-lasting station-
ary programs averages about 10-25%, while 
the annual retention level equals from 20 to 
30%. The main predictors of  program aban-
donment are severe criminal history and pro-
nounced psychopathology. TZ program is ef-
ficient for those who stay in it long enough 
to benefit from the results of  treatment [1,2].
Quality of  life has drawn much interest of  
medical investigators in the last decade [7]. 
Compared to the earlier traditional clinical 
studies, measuring the quality of  life is more 
convenient for the evaluation of  social and 
emotional dimension of  disease course and 
treatment success and provide the general 
insight of  the influence that the disease and 
the treatment have on patients functioning in 
several important areas of  life [8]. 
The concept of  quality of  life has also 
been accepted an an important method of  
evaluating the programs of  treatment of  the 
addictions to psychoactive substances [9]. 
Programs of  maintenance with methadone 
are probably the most investigated in the field 
of  treatment of  addiction to opiates and the 
dominant conclusion is that methadone is an 
efficient treatment tool and thus, lately, easy 
as possible access to these programs ‘to all 
who need them’ is promoted. [10]. The ef-
ficiency of  methadone therapy is mostly sup-
ported by the indicators which appear on the 
broader social level (social functioning, crimi-
nality level decrease, reduction of  psychoac-
tive substances abuse) while a smaller number 
of  studies analyzed the perception of  health 
and well-being from the perspective of  the 
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patients themselves, while the therapy with 
methadone is mostly considered a “biomedi-
cal treatment for social rehabilitation ” [11]. 
So far, it has been several efforts to evalu-
ate the influence of  opiate addiction and its 
treatment to the quality of  patients’ life. A 
smaller number of  previous studies dealt 
with various maintenance treatments, while 
the treatment in frame of  therapeutic com-
munity has not yet been the object of  such 
studies [12,13]. 
That is why the aim of  this study had been 
to compare the quality of  addicts’ life among 
those treated in methadone maintenance 
programs and those treated in the therapeu-
tic communities.
Materials and methods
A cross-study has been carried out in the 
Center for Prevention and Out-patient Treat-
ment of  Addictions in Mostar. The study in-
cluded 60 subjects, all of  them males, mean 
age 31,87±7 (M±SD) years, mean addiction 
duration 6,78±5,02 (M±SD) years. All of  the 
subjects were heroin addicts referring to the 
Center for Prevention and Out-patient Treat-
ment of  Addictions in Mostar, who had satis-
fied  the DSM-IV criteria for establishing the 
diagnosis of  addiction.
Subjects have been divided in three 
groups: 
1. group of  just-admitted patients (N=20)
2. group of  patients who had spent six 
months in a methadone program (N=20)
3. group of  patients who had spent six 
months in a therapeutic community pro-
gram (N=20).
In this study, we have gathered data for 
social-demographic variables such as age, 
education, marital and professional status 
and variables related to the addiction status, 
such as duration of  addiction, manner of  
drug administration, alcohol use and pres-
ence of  HCV, HBV or HIV viral infections. 
For the estimation of  quality of  life, we have 
used the “Quality of  life index”, to measure 
the subjects’ perception of  the important ar-
eas of  life, such as health and functioning in 
the fields of  social, economic, psychological, 
spiritual and family domains. 
The study had been approved by the Ethi-
cal committee and carried out according to 
the Rules of  Good Clinical Practice and Hel-
sinki Declaration.
Statistical analysis of data
The study results have been stored in MS 
Excel 2007 database and SPSS 17 statisti-
cal program has been used for all statistical 
calculations. In the analysis of  data, we have 
used the methods of  descriptive statistics. 
Non-parametric variables have been shown 
as frequencies and percentages. Parametric 
variables have been shown as an arithmeti-
cal means and standard deviations. The data 
distribution has been analyzed by means of  
using the Kolmogoroff-Smirnoff  Test. The 
observed differences have been tested for 
significance using the Chi-square Test and 
Fisher’s Exact Test for categorical variables. 
Testing the differences between the paramet-
ric variables has been done using the One-
way Analysis of  Variance and the differences 
between the individual groups by means of  
Sheffe Test. The level of  statistical signifi-
cance has been set to p<0,05. 
Results
Social-demographic and clinical character-
istics of  the sample 
The majority of  patients from our sam-
ple had finished the secondary school educa-
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tion, a smaller number finished universities, 
while there were no subjects with just the 
primary school education (χ2=45,067; df=1; 
p<0,001) The most of  the subjects have not 
been married, while a smaller proportion had 
been married or divorced (χ2=43,600; df=2; 
p<0,001). The data concerning the profes-
sional status had indicated that a significantly 
greater number of  subjects had been unem-
ployed (χ2=38,400; df=1; p<0,001). Signifi-
cantly more of  the subjects lived with their 
parents, while a smaller percentage had lived 
alone (χ2=38,400; df=1; p<0,001). The great-
est percentage of  our subjects had been tak-
ing drugs intravenously, a smaller percent-
age sniffed, while the smallest percentage of  
them had been taking heroin by means of  
smoking (χ2=33,400; df=2; p<0,001). 
We have also gathered the data concern-
ing the prevalence of  sexually transmitted 
diseases and diseases transmitted by blood, 
such as HIV, HCV and HBV. We have not 
found any subjects infected with HIV in our 
sample, while more than 50 % of  the subjects 
from the sample had been infected with hep-
atitis C virus (χ2=1,143; df=1; p=0,285). The 
majority of  subjects had been consuming no 
alcohol at all or drinking sporadically, while a 
smaller number of  subjects had been drink-
ing alcohol regularly every day or abstaining 
(χ2=27,200; df=5; p<0,001). 
Using the Chi-square test, we have found 
a significant difference in the level of  edu-
cation between the groups tested; more sub-
jects at the admission had finished the univer-
sity education, while in the other two groups, 
those with secondary school education pre-
vailed. There were not any significant differ-
ences between the groups neither concerning 
the marital and professional status, nor in the 
living conditions (Table 1). 
Table 1. Social-demographic characteristics 
Group
χ2 pAdmission Methadone Community
N % N % N %
Education 6,209 0,030*
SSS 16 80,0 20 100,0 20 100,0
VSS 4 20,0 0 0,0 0 0,0
Marriage 5,901 0,184*
Not-married 14 70,0 12 60,0 18 90,0
Married 4 20,0 4 20,0 2 10,0
Divorced 2 10,0 4 20,0 0 0,0
Work 0,223 1*
Unemployed 18 90,0 18 90,0 18 90,0
Employed 2 10,0 2 10,0 2 10,0
Living with 0,223 1*
Alone 2 10,0 2 10,0 2 10,0
Family 18 90,0 18 90,0 18 90,0
*Fisher’s Exact Test
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As shown in Table 2, the alcohol had been 
consumed in greater percentage among the 
Table 2. Habits of  alcohol drinking in the groups tested
Group
χ2 pAdmission Methadone Community
N % N % N %
Alcohol 18,679 0,017*
Does not drink 8 40,0 4 20,0 10 50,0
Occasionally 6 30,0 8 40,0 2 10,0
Weekends 2 10,0 2 10,0 4 20,0
Frequently 0 0,0 4 20,0 2 10,0
Every day 4 20,0 0 0,0 0 0,0
Abstinent 0 0,0 2 10,0 2 10,0
*Fisher’s Exact Test
Table 3. The differences in variables related to the addiction between the groups tested
Group
χ2 pAdmission Methadone Community
N % N % N %
Way of  administration 16,915 0,001
Iv 10 50,0 10 50,0 20 100,0
Sniffing 8 40,0 8 40,0 0 0,0
Smoking 2 10,0 2 10,0 0 0,0
HCV 23,333 <0,001
No 12 66,7 12 66,7 0 0,0
Yes 6 33,3 6 33,3 20 100,0
HBV 2,495 0,322*
No 18 100,0 18 100,0 18 90,0
Yes 0 0,0 0 0,0 2 10,0
*Fisher’s Exact Test
subjects from methadone group, mostly spo-
radically, in special occasions
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As visible from Table 3, the greatest per-
centage of  patients who had administered 
heroin to organism intravenously belonged 
to the group of  subjects from therapeutic 
communities and this group had also showed 
the greatest level of  HCV infection, while 
no significant differences had been observed 
concerning the HBV infection.
Using the One-way analysis of  variance, 
we have found significant differences in qual-
ity of  life between the groups tested (Table 
4). 
Table 4. The differences in quality of  life between the groups tested
QOLY Index
Groups
F pAdmission Methadone Community
X SD X SD X SD
Scale of  satisfaction 106,50 21,867 136,10 28,853 134,60 21,780 9,344 <0,001
Scale of  importance 150,10 22,861 173,40 5,734 166,40 16,301 10,443 <0,001
Table 5. Multiple comparisons; Scheffe Test
QOLY Index Group p
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For multiple comparisons between the 
groups, we have used Sheffe Post-hoc Test 
(Table 5). The groups of  subjects treated in 
methadone program and subjects in the pro-
gram of  therapeutic community showed sig-
nificantly higher scores on scales of  satisfac-
tion with important areas of  life (p=0,001; 
p=0,003; Schefe post hoc test) and on scales 
of  importance od particular areas of  life 
(p<0,001; p=0,011; Schefe post hoc test) 
compared to the group of  patients just admit-
ted to treatment.  There were no significant 
differences in scales previously mentioned 
between the groups of  patients from metha-
done programs and those from therapeutic 
communities (p=0,981; p=0,414; Schefe post 
hoc test). 
Discussion
According to the results of  this study, the 
most of  the patients from our sample had 
a secondary school education and were of  
similar age, unmarried, mostly unemployed 
and only a smaller number of  them were liv-
ing alone, out of  their primary families. The 
groups tested had not significantly differed 
according to living conditions which reflect 
the quality of  life. The results of  analysis of  
the addiction variables had shown that a ma-
jority of  subjects administered the drug in-
travenously, that there were no significant 
differences concerning the duration of  ad-
diction and that the most of  the subjects had 
drunk no alcohol. We have not detected any 
cases of  HIV infection, while a significant 
number of  subjects had been infected with 
hepatitis B virus. This study revealed signifi-
cant differences in quality of  life between the 
groups tested. The groups of  subjects who 
had undergone the methadone program and 
the group of  those treated in the frame of  
therapeutic community showed significantly 
higher scores on quality of  life scales com-
pared to the group of  just-admitted patients, 
while there were no such differences be-
tween the group of  subjects who had under-
gone the methadone program and the group 
of  those treated in the frame of  therapeutic 
community.
The study carried out by Giacomuzzi et al. 
included 67 subjects addicted to opiates, 38 
of  which had been treated with methadone 
and 29 with buprenorphine. The subjects 
have been similar according to all their ba-
sic characteristics. Neither subjects from bu-
prenorphine program, nor those from meth-
adone program had shown any significant 
differences in any areas of  quality of  life after 
24 weeks spent in the program of  treatment. 
The results of  this study suggest that the 
treatment with buprenorphine or methadone 
is equally effective considering the effect to 
quality of  life, which is in concordance with 
this study [13]. 
In a similar study, dealing with patients in 
methadone maintenance program of  treat-
ment, Torrens et al. have analyzed the chang-
es of  quality of  life related to the health 
status of  subjects followed throughout a 
three-year period. The results of  this study 
have shown that the patients on methadone 
therapy showed a significant improvement of  
measured quality of  life parameters already 
early in the course of  study, inside the period 
of  12 months, which is also in accordance 
with the results of  our study [9]. 
There were also several other studies that 
had reported that heroin addicts at the ad-
mission to methadone programs already have 
a high level of  physical and mental health 
damage, but also that the quality of  life sig-
nificantly improves in the course of  remain-
ing in programs of  methadone maintenance. 
This improvement is the most visible at the 
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end of  the first month of  treatment, and de-
tectable even before the other indexes are 
modified (like heroin abuse and criminal ac-
tivities) [14]. 
Conclusion
The data obtained suggest that the treat-
ment with methadone is equally effective as 
a stay in therapeutic community concerning 
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Razlike u kvaliteti života ovisnika o heroinu liječenih u metadonskom programu 
i ovisnika liječenih u programu terapijske zajednice
Sažetak – Cilj istraživanja bio je usporediti kvalitetu života ovisnika liječenih u supstitucijskom metadons-
kom programu i ovisnika na rehabilitaciji u terapijskoj zajednici. Provedeno je presječno istraživanje u Cen-
tru za prevenciju i izvanbolničko liječenje ovisnosti u Mostaru. U istraživanje je uključeno 60 ispitanika. Svi 
su ovisnici o heroinu koji su se javili u Centar za prevenciju i izvanbolničko liječenje ovisnosti u Mostaru, a 
koji zadovoljavaju DSM-IV kriterije za dijagnozu ovisnosti.  Ispitanici su podijeljeni u tri skupine: 1) skupinu 
tek primljenih pacijenata (N=20), 2) skupinu pacijenata koji su proveli 6 mjeseci u metadonskom programu 
(N=20) i3) skupinu pacijenta koji su proveli 6 mjeseci u programu terapijske zajednice (N=20). U istraživanju 
su prikupljane socidemografske varijable kao što su dob, edukacija, bračni i radni status, te varijable vezane 
za ovisnost kao što su dužina ovisničkog staža, način uzimanja droge, uporaba alkohola te prisutnosti in-
fekcije virusima HCV, HBV i HIV. Za procjenu kvalitete života koristio  “Quality of life index” kojim se mjerila 
percepcija važnih životnih područja kao što su zdravlje i funkcioniranje, socijalno i ekonomsko, psihološko i 
spiritualno, te obiteljsko područje. Većina ispitanika u uzorku je bila srednjoškolski obrazovana, podjednake 
dobi, neoženjeni, najveći dio je bio bez posla, a samo mali broj je živio sam van primarne obitelji. Ispitivane 
skupine se nisu značajno razlikovale prema uvjetima življenja koji su pokazatelji kvalitete života. Rezultati 
istraživanja ovisničkih varijabli pokazuju da je većina ispitanika drogu uzimala intravenskim putem, nije bilo 
razlika u trajanju ovisničkog staža među skupinama, te ih većina nije pila alkohol. Nije nađen nijedan slučaj 
infekcije HIV-om, a veći broj ispitanika u uzorku su bili zaraženi virusom hepatitisa C, dok je vrlo mali  broj 
ispitanika bio zaražen virusom hepatitisa B. U ovom istraživanju su nađene značajne razlike u kvaliteti života 
među ispitivanim skupinama. Skupine ispitanika liječenih u metadonskom programu i u programu terapijske 
zajednice pokazale su značajno veće rezultate na skalama kvalitete života u odnosu na skupinu tek primljenih 
pacijenata, a između skupine ispitanika koji su bili u metadonskom programu liječenja i skupine u terapijskoj 
zajednici nije bilo takvih razlika. Dobiveni podaci ukazuju na činjenicu da je liječenje metadonom podjednako 
djelotvorno kao i boravak u terapijskoj zajednici po utjecaju na promjene u kvaliteti života ispitanika.
Ključne riječi: ovisnost o opijatima, metadon, buprenorfin, kvaliteta života
